Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use.

Abstract

BACKGROUND AND PURPOSE Orolingual angioedema (OA) is an uncommon but potentially life-threatening complication of treatment with recombinant tissue plasminogen activator (rt-PA; alteplase) during acute ischaemic stroke. This study aimed to determine the incidence of rt-PA-related OA in an Asian stroke population and the risk of pre-stroke anti-hypertensive… (More)
DOI: 10.1111/ene.12472

Topics

5 Figures and Tables

Cite this paper

@article{Lin2014OrolingualAA, title={Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use.}, author={S D Lin and S B Tang and L Y Tsai and S. I. Yeh and Y-J Hsiao and Yi-Wen Chen and K L Chen and B Yip and L J Shen and F L Wu and J-S Jeng}, journal={European journal of neurology}, year={2014}, volume={21 10}, pages={1285-91} }